Eterna Therapeutics News

Eterna Therapeutics | 424B3: Prospectus

Nov 19, 2024 05:21

Eterna Therapeutics | 424B3: Prospectus

Nov 19, 2024 05:21

Eterna Therapeutics | EFFECT: Others

Nov 18, 2024 19:03

Eterna Therapeutics | D: Filing D

Nov 14, 2024 19:51

Eterna Therapeutics | D: Filing D

Nov 14, 2024 19:46

Eterna Therapeutics | UPLOAD: Others

Nov 14, 2024 11:33

Eterna Therapeutics | CORRESP: CORRESP

Nov 14, 2024 11:31

Eterna Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 13, 2024 06:19

Eterna Therapeutics | S-1: General form for registration of securities under the Securities Act of 1933

Nov 6, 2024 05:36

Eterna Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Cherington Charles

Nov 6, 2024 01:46

Eterna Therapeutics | 8-K: Current report

Oct 30, 2024 04:35

Eterna Therapeutics | ARS: Annual Report to Security Holders

Oct 17, 2024 04:19

Eterna Therapeutics | DEF 14A: Definitive information statements

Oct 8, 2024 05:15

Eterna Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Sep 28, 2024 04:50

Eterna Therapeutics | 8-K: Current report

Sep 28, 2024 04:19

Eterna Therapeutics | 8-K: Current report

Sep 26, 2024 04:41

Eterna Therapeutics | 8-K: Current report

Sep 24, 2024 04:34

Eterna Therapeutics | 8-K: Current report

Aug 20, 2024 05:03

Eterna Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 14, 2024 04:36

4: Statement of changes in beneficial ownership of securities-Officer Gurrola Sandra M

Jun 26, 2024 04:36